Safety cohort data from phase II study of prexigebersen plus frontline therapies for AML April 6, 2021
Advaxis and Columbia University Irving Medical Center enter agreement on phase I study of ADXS-504 April 6, 2021
Study to assess analytical treatment interruption in participants who contracted HIV in VRC-01 trial April 6, 2021